YEAR
- 2020.06.29 Salt causes aging-associated hypertension via vascular Wnt5a under Klotho deficiency Kawarazaki W, Mizuno R, Nishimoto M, Ayuzawa N, Hirohama D, Ueda K, Kawakami-Mori F, Oba S, Marumo T, Fujita. T. J Clin Invest. 2020 Jun 29;134431. doi: 10.1172/JCI134431. Online ahead of print.
- 2020.06.17 Organoid-based ex vivo reconstitution of Kras-driven pancreatic ductal carcinogenesis. Matsuura T, Maru Y, Izumiya M, Hoshi D, Kato S, Ochiai M, Hori M, Yamamoto S, Tatsuno K, Imai T, Aburatani H, Nakajima A, Hippo Y.Carcinogenesis. 2020 Jun 17;41(4):490-501. doi: 10.1093/carcin/bgz122
- 2020.06.10 A novel sensitive detection method for DNA methylation in circulating free DNA of pancreatic cancer. Shinjo K, Hara K, Nagae G, Umeda T, Katsushima K, Suzuki M, Murofushi Y, Umezu Y, Takeuchi I, Takahashi S, Okuno Y, Matsuo K, Ito H, Tajima S, Aburatani H, Yamao K, Kondo Y.PLoS ONE. 2020;15(6):e0233782. doi: 10.1371/journal.pone.0233782
- 2020.06.02 Base editors for simultaneous introduction of C-to-T and A-to-G mutations Sakata RC, Ishiguro S, Mori H, Tanaka M, Tatsuno K, Ueda H, Yamamoto S, Seki M, Masuyama N, Nishida K, Nishimasu H, Arakawa K, Kondo A, Nureki O, Tomita M, Aburatani H, Yachie N.Nat Biotechnol. 2020 Jun 2. doi: 10.1038/s41587-020-0509-0.
- 2020.05.26 Neoantigen load and HLA-class I expression identify a subgroup of tumors with a T-cell-inflamed phenotype and favorable prognosis in homologous recombination-proficient high-grade serous ovarian carcinoma Matsushita H, Hasegawa K, Oda K, Yamamoto S, Asada K, Karasaki T, Yabuno A, Nishijima A, Nejo T, Kobayashi Y, Sato S, Ikeda Y, Miyai M, Takahashi Y, Yamaguchi R, Fujiwara K, Aburatani H, Kakimi K.J Immunother Cancer. 2020 May;8(1):e000375. doi: 10.1136/jitc-2019-000375.
- 2020.05.22 Mesenchymal tumours with RREB1-MRTFB fusion involving the mediastinum: extra-glossal ectomesenchymal chondromyxoid tumours? Makise N, Mori T, Kobayashi H, Nakagawa K, Ryo E, Nakajima J, Kohsaka S, Mano H, Aburatani H, Yoshida A, Ushiku T.Histopathology. 2020 Jun;76(7):1023-1031. doi: 10.1111/his.14080
- 2020.05.08 Pemafibrate, a selective PPARα modulator, prevents non-alcoholic steatohepatitis development without reducing the hepatic triglyceride content. Sasaki Y, Asahiyama M, Tanaka T, Yamamoto S, Murakami K, Kamiya W, Matsumura Y, Osawa T, Anai M, Fruchart JC, Aburatani H, Sakai J, Kodama T.Sci Rep. 2020 May 08;10(1):7818. doi: 10.1038/s41598-020-64902-8
- 2020.05.07 Yeast-Based Genetic Interaction Analysis of Human Kinome. Kim JH, Seo Y, Jo M, Jeon H, Lee WH, Yachie N, Zhong Q, Vidal M, Roth FP, Suk K.Cells. 2020 May 07;9(5). doi: 10.3390/cells9051156
CLOSE